| Literature DB >> 23476088 |
Abstract
Brazil recently announced an agreement between its Bio-Manguinhos vaccine unit and two US companies to research and develop a new yellow fever vaccine. Claudia Jurberg and Julia D'Aloisio talk to Jaime Benchimol about the controversial history of the development of the vaccine that benefits millions of people today.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23476088 PMCID： PMC3590627 DOI： 10.2471/BLT.13.030313
Source DB: PubMed Journal: Bull World Health Organ ISSN： 0042-9686 Impact factor: 9.408